immunovant inc glp-1 receptor agonist products Agonists: A Comprehensive Overview ONE + Receptor Activator features two clinically validated botanical ingredients The Landscape Of GLP-1 Receptor

I discovered GLP-1 while studying glucagon, a hormone that increases blood sugar levels

This 3% reduction is calculated to have a total possible impact of up to $12 billion dollars

The study was a randomized, double-blind trial that analyzed 156 patients treated with dopaminergic therapy

Both of these GLP-1/glucagon co-agonists, one based on a glucagon-derived backbone [922] and the other based on an oxyntomodulin-derived sequence [923], had superior weight loss in obese rodents relative to matched analogs that were selective in activity towards GLP-1R

A Novel Glucose-Sensing Mechanism Contributing to Glucagon-Like Peptide-1 Secretion From the GLUTag Cell Line

To view or add a comment, sign in A lot of GOOD news today in biotech + pharma: Breast cancer win in Ph3 trial for AstraZeneca + Daiichi Sankyo US (survival benefit vs chemotherapy) TCGX (TCG Crossover) raises $1.3B third fund focused on biotech + life sciences Trogenix's "Trojan Horse"-tech for cancer biotech lands 70M Series A AstraZeneca + Algen Biotechnologies sign up to $555M AI-powered drug discovery partnership Chiesi Group + Arbor Biotechnologies up to $2.1B rare disease partnership Eli Lilly and Company to invest up to $1B in Indian-based CDMO partnerships For all the news, check out the full (free) TLDR Biotech newsletter here ---------------------------------------- One skimmable email per day to keep up with biotech and pharma Big thanks to Promoveo Health for supporting this newsletter - they've built 100+ pharma sales teams for companies of all sizes, and they can do it for your org as well